| 000 | 01585 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516195308.0 | ||
| 264 | 0 | _c20141112 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a2476-762X | ||
| 024 | 7 |
_a10.7314/apjcp.2014.15.1.3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAkaza, Hideyuki | |
| 245 | 0 | 0 |
_aJapanese Cancer Association Meeting UICC International session--what is cost-effectiveness in cancer treatment? _h[electronic resource] |
| 260 |
_bAsian Pacific journal of cancer prevention : APJCP _c2014 |
||
| 300 |
_a3-10 p. _bdigital |
||
| 500 | _aPublication Type: Congress | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 | _aEngland |
| 650 | 0 | 4 | _aHealth Services Accessibility |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPrescription Fees |
| 650 | 0 | 4 | _aRepublic of Korea |
| 650 | 0 | 4 | _aTechnology Assessment, Biomedical |
| 700 | 1 | _aKawahara, Norie | |
| 700 | 1 | _aRoh, Jae Kyung | |
| 700 | 1 | _aInoue, Hajime | |
| 700 | 1 | _aPark, Eun-Cheol | |
| 700 | 1 | _aLee, Kwang-Sig | |
| 700 | 1 | _aKim, Sukyeong | |
| 700 | 1 | _aHayre, Jasdeep | |
| 700 | 1 | _aNaidoo, Bhash | |
| 700 | 1 | _aWilkinson, Thomas | |
| 700 | 1 | _aFukuda, Takashi | |
| 700 | 1 | _aJang, Woo Ick | |
| 700 | 1 | _aNogimori, Masafumi | |
| 773 | 0 |
_tAsian Pacific journal of cancer prevention : APJCP _gvol. 15 _gno. 1 _gp. 3-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.7314/apjcp.2014.15.1.3 _zAvailable from publisher's website |
| 999 |
_c23546088 _d23546088 |
||